Red and Green Indicators: A New perspective on Glaucoma
In this episode of Dr. Chris Lievens’ The 4-Eyed Professor podcast, he tackles the complexities and misconceptions surrounding red and green indicators.
![](https://www.heidelbergengineering.com/us/wp-content/themes/hdeng-corporate/assets/img/icon-link.png)
In this episode of Dr. Chris Lievens’ The 4-Eyed Professor podcast, he tackles the complexities and misconceptions surrounding red and green indicators.
In this ASCRS Healio Video Perspective, David L. Cooke, MD, describes a challenging case of myopia and astigmatism after cataract surgery.
In this video interview at ARVO 2024, Edmund Tsui, MD, presents an overview of his team's research using swept-source OCT with the ANTERION platform to look at anterior chamber cells in patients with uveitis.
Join your host, Chris Lievens, OD, MS, PhD, and guest Jim Williamson, OD, FAAO, as they dive into the facinating world of OCT imaging. Discover the intricacies of OCT technology and journey through the evolution of retinal imaging from the past to the present, while speculating on future directions.
In an interview with Ophthalmology Times, Osamah Saeedi, MD, MS, explained the key findings from the poster he presented at the ARVO Imaging in the Eye Conference in Seattle.
In this case study of a 72-year-old diabetic patient with compromised vision, James Fanelli, OD, highlights the importance of stepping back from micron-level details in OCT interpretations to gain a broader understanding of ocular health
Clinicians are keenly aware of the need to keep patients onboard with treatment and never more so with a condition which shows no real benefit of treatment. Visualisation - black means fluid, and grey means abnormal blood vessels - is the key to ensuring that patients return regularly and engage with sight-saving therapies
With an array of breakthrough drugs in the pipeline, clinicians are being urged to upskill and healthcare managers should prepare patient pathways. Mindful of costs, the price of treatment may be considerably less than residential care for a patient who is no longer able to look after themselves and requires round the clock nursing.
Causing three times the sight loss of any other ocular morbidity, AMD can be a devastating diagnosis. By using AI to identify the patients with the greatest opportunity for effective treatment, there is a cause for optimism as the enormous benefits of machine learning are put to work.
In this video highlight from ASCRS 2024, James Lewis, MD, describes Heidelberg Engineering's ANTERION as the “most exciting piece of equipment I’ve acquired in the last decade.”